Global Hemoglobinopathies Market Share to hit at a CAGR of 10.1% by 2027
Search jobs Global Hemoglobinopathies Market Share to hit at a CAGR of 10.1% by 2027 Hemoglobinopathies Market by Type (Sickle Cell Disease, Thalassemia, Others), Diagnosis (Genetic Testing, Red Blood Cell (RBC) Count Test,Hemoglobin Isoelectric (Hb IEF) Focusing, Hemoglobin By High Performance Liquid Chromatography (HPLC) Test,Hemoglobin Solubility Test, Hemoglobin Electrophoresis (Hb ELP) Test), Therapy (Blood Transfusion,Bone Marrow Transplant, Iron Chelation Therapy...
United States Mark Stone Asia Pacific Alnylam Pharmaceuticals Celgene Corporation Emmaus Life Sciences Inc
Source: pharmiweb.com